Latest news with #NCIMB


The Herald Scotland
30-04-2025
- Business
- The Herald Scotland
Scottish firm backed by investment fund to create new jobs
The money has been provided by the Investment Fund for Scotland, which is managed by Maven Capital Partners and the Scottish National Investment Bank. Read more: NCIMB's facility at the Wellhead Industrial Estate opened in 2023 and includes microbiology labs, cold storage and molecular suites. Chief executive Edward Green said the fresh investment will allow the company to meet growing demand and create new jobs. "The funding is transformational for the business, allowing us to scale in the northeast of Scotland and better support our customer's needs in life sciences," he said. "In addition, it allows us to deliver our long-term vision to deploy our unique microbial platform to deliver impactful biotechnology solutions addressing grand societal challenges including decarbonisation, climate change, food security and healthy living.' The £150m Investment Fund for Scotland is designed to drive sustainable economic growth by supporting innovation and creating local opportunities for new and growing businesses. It does this by providing early-stage funding to firms that might not otherwise receive investment. Businesses previously backed by the fund include the long-established Wilsons Pet Food, water treatment specialist Scotmas Group, and premium Indian ready meals business Praveen Kumar. The fund provides loans from £25,000 to £2m, and equity investment of up to £5m. 'NCIMB is globally recognised for its culture collection and for delivering high-quality microbiology services and is uniquely positioned to meet growing market demand for contract research organisations with deep domain expertise," said David Milroy, partner at Maven. "This investment will allow the company to scale its commercial operations, expand its licensing business, and enhance its service offering to customers worldwide. We are delighted to join the team at this point in the company's journey and look forward to helping them further scale the business.'


Press and Journal
29-04-2025
- Business
- Press and Journal
How Aberdeen bacteria collection is tackling world's biggest problems
A pioneering lab in Aberdeen that stores some of the world's most useful bacteria has received a £1.7 million investment to scale its operations and tackle some of today's most urgent scientific challenges. Dyce-based biotech lab NCIMB is home to the UK's largest bacterial culture collection, the National Collection of Industrial, Food and Marine Bacteria. These microscopic powerhouses drive innovation across industries — from pharmaceuticals and sustainable technologies to food safety and even the science behind keeping your home smelling fresh, thanks to products like Febreze. NCIMB plays a key role in preserving and supplying them from its £4m purpose-built base in Wellheads Industrial Estate. The funding, from Maven Capital Partners and the Scottish National Investment Bank, will support NCIMB's ambitious growth plans. Opened in 2023, the state-of-the-art premises feature advanced microbiology labs, cold storage, and molecular suites. Dr Edward Green, NCIMB's chief executive, said the investment would allow the business to meet growing demand and create new local jobs. 'The funding is transformational for the business, allowing us to scale in the north-east of Scotland and better support our customers' needs in life sciences,' he said. 'It allows us to deliver our long-term vision to deploy our unique microbial platform to deliver impactful biotechnology solutions addressing grand societal challenges including decarbonisation, climate change, food security and healthy living.' The company plans to grow its team from 23 to 30 employees by the end of this year. Founded in 1982 with the University of Aberdeen's original bacteria collection — which dates back more than 75 years — NCIMB now holds over 10,000 strains. Many of these microbes are already used to produce everyday essentials, such as antibiotics, food ingredients, and industrial enzymes. 'It has been collected over many decades and serves as a national reference collection for anyone who wants to get hold of a microbial strain, primarily for some beneficial purpose,' added Dr Green. 'We have only scratched the surface in terms of the ways microbes can be used to benefit mankind and tackle many of the big issues faced by society, including climate change, food security and healthy ageing. 'It is incredibly lucky that somebody had the foresight to establish this collection of industrial, food and marine bacteria.' The Maven team was first introduced to NCIMB at an IFS Roadshow in Aberdeen, hosted by the British Business Bank. This latest investment is intended to help NCIMB generate more revenue from its collection and grow the business, with future spin-out companies expected. Dr Green added: 'We want to make our collection more accessible, more useful and get it out to more people than we currently do – in a format that I think de-risks for the end-user.' The investment will allow NCIMB to grow its microbiology services, expand its specialist licensing business, and develop new offerings that help customers choose and use the right bacterial strains for their needs. David Milroy, partner at Maven said NCIMB is uniquely positioned to meet growing demand for contract research organisation's with deep domain expertise. He added: 'We are delighted to join the team at this point in the company's journey and look forward to helping them further scale the business.' Alastair McMillen of the Scottish National Investment Bank said: 'As an impact investor, we are attracted to NCIMB's commercial potential as well as the innovation it can unlock to address global challenges such as climate change and food insecurity.'